Heidelberg, October 20, 2006 - LION bioscience AG received today an
adjustment of the voluntary take-over bid to the LION shareholders by
the two investment- companies of the Hopp family, DH-Capital GmbH &
Co. KG und OH Beteiligungen GmbH & Co. KG. The management and
supervisory board of LION bioscience AG will release a qualified
statement regarding this adjustment within the next days.